Citi raised the firm’s price target on Colgate-Palmolive (CL) to $108 from $103 and keeps a Buy rating on the shares. The company reported “weak” Q1 results but a lower negative 2025 earnings cut relative to peers, the analyst tells investors in a research note. The firm believes Colgate has levers to address tariff headwinds with relatively greater pricing power and flexibility.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CL:
- Colgate-Palmolive Stock (CL) Rangebound on Positive Q1 Results but Lowered Full-Year Outlook on Tariff Concerns
- Colgate-Palmolive Reports Resilient Q1 2025 Results
- Colgate-Palmolive’s Resilient Q1 2025 Earnings Call
- Colgate-Palmolive sees $200M gross impact to costs from tariffs
- Colgate-Palmolive seeing ‘soft” Q2